What is the proper dosage for Lunesta (eszopiclone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Proper Dosage for Lunesta (Eszopiclone)

The recommended starting dose of Lunesta (eszopiclone) is 1 mg, which can be increased to 2 mg or 3 mg if clinically indicated, with a maximum daily dose of 3 mg taken immediately before bedtime. 1

Dosage Guidelines Based on Patient Population

Standard Adult Dosing (18-64 years)

  • Starting dose: 1 mg
  • Standard effective dose: 2-3 mg
  • Maximum dose: 3 mg once daily
  • Indication: Both sleep onset and sleep maintenance insomnia 1, 2

Elderly Patients (≥65 years) or Debilitated Patients

  • Starting dose: 1 mg
  • Maximum dose: 2 mg once daily
  • The 1 mg dose is primarily for sleep onset difficulties in older adults 1
  • Elderly patients have longer elimination half-life (approximately 9 hours vs. 6 hours in younger adults) 3

Special Populations

  • Severe hepatic impairment: Maximum 2 mg 1
  • Patients taking potent CYP3A4 inhibitors: Maximum 2 mg 1

Timing and Administration

  • Take immediately before bedtime
  • Avoid taking with or immediately after a heavy, high-fat meal as this reduces absorption and effectiveness 1
  • Duration of effect lasts up to 6 hours, which helps with sleep maintenance 4

Efficacy for Different Insomnia Types

  • 2 mg dose: Effective for sleep onset difficulties
  • 3 mg dose: More effective for sleep maintenance issues 5
  • Eszopiclone has demonstrated efficacy for both sleep onset and maintenance insomnia, with significant reductions in:
    • Sleep onset latency (SOL)
    • Number of awakenings
    • Wake time after sleep onset (WASO) 6, 3

Important Considerations and Precautions

Dose Adjustment with CNS Depressants

  • Dosage adjustments may be necessary when combined with other CNS depressant drugs due to potentially additive effects 1

Side Effects

  • Most common: Unpleasant/bitter taste, headache, dizziness, dry mouth, dyspepsia 3, 7
  • More serious but less common: Memory impairment, psychiatric adverse effects, depression, anxiety, and accidental injury 6

Safety Concerns

  • FDA warnings include risk of daytime memory and psychomotor impairment, abnormal thinking, behavioral changes, complex behaviors (like sleep driving), and depression 6
  • Higher morning blood levels following 2 mg or 3 mg doses may increase the risk of next-day impairment of driving and other activities requiring alertness 1

Long-term Use

  • Unlike zolpidem and zaleplon, eszopiclone is not restricted to short-term use 5
  • Studies have shown sustained efficacy for up to 12 months without development of tolerance 3, 8

Clinical Pearls

  • Always use the lowest effective dose to minimize side effects and next-day impairment 1
  • Eszopiclone has shown efficacy in both primary insomnia and co-morbid insomnia (when insomnia coexists with other conditions) 8
  • Unlike benzodiazepines, eszopiclone does not significantly alter slow wave sleep or REM sleep 3
  • Consider 2 mg dose for sleep maintenance insomnia in elderly patients, as this dose has been shown to improve next-day functioning and daytime alertness 7

Remember that while eszopiclone is effective for insomnia, it should be used as part of a comprehensive approach that may include cognitive behavioral therapy for insomnia (CBT-I) and good sleep hygiene practices for optimal outcomes.

References

Guideline

Management of Early Sleep Awakening

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Eszopiclone: its use in the treatment of insomnia.

Neuropsychiatric disease and treatment, 2007

Research

Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent.

Proceedings (Baylor University. Medical Center), 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Eszopiclone for the treatment of insomnia.

Expert opinion on pharmacotherapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.